X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
13
PharmaCompass offers a list of Palonosetron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Palonosetron manufacturer or Palonosetron supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Palonosetron manufacturer or Palonosetron supplier.
PharmaCompass also assists you with knowing the Palonosetron API Price utilized in the formulation of products. Palonosetron API Price is not always fixed or binding as the Palonosetron Price is obtained through a variety of data sources. The Palonosetron Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Palonosetron HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Palonosetron HCl, including repackagers and relabelers. The FDA regulates Palonosetron HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Palonosetron HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Palonosetron HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Palonosetron HCl supplier is an individual or a company that provides Palonosetron HCl active pharmaceutical ingredient (API) or Palonosetron HCl finished formulations upon request. The Palonosetron HCl suppliers may include Palonosetron HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Palonosetron HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Palonosetron HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Palonosetron HCl active pharmaceutical ingredient (API) in detail. Different forms of Palonosetron HCl DMFs exist exist since differing nations have different regulations, such as Palonosetron HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Palonosetron HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Palonosetron HCl USDMF includes data on Palonosetron HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Palonosetron HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Palonosetron HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Palonosetron HCl Drug Master File in Japan (Palonosetron HCl JDMF) empowers Palonosetron HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Palonosetron HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Palonosetron HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Palonosetron HCl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Palonosetron HCl Drug Master File in Korea (Palonosetron HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Palonosetron HCl. The MFDS reviews the Palonosetron HCl KDMF as part of the drug registration process and uses the information provided in the Palonosetron HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Palonosetron HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Palonosetron HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Palonosetron HCl suppliers with KDMF on PharmaCompass.
A Palonosetron HCl written confirmation (Palonosetron HCl WC) is an official document issued by a regulatory agency to a Palonosetron HCl manufacturer, verifying that the manufacturing facility of a Palonosetron HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Palonosetron HCl APIs or Palonosetron HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Palonosetron HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Palonosetron HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Palonosetron HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Palonosetron HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Palonosetron HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Palonosetron HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Palonosetron HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Palonosetron HCl suppliers with NDC on PharmaCompass.
Palonosetron HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Palonosetron HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Palonosetron HCl GMP manufacturer or Palonosetron HCl GMP API supplier for your needs.
A Palonosetron HCl CoA (Certificate of Analysis) is a formal document that attests to Palonosetron HCl's compliance with Palonosetron HCl specifications and serves as a tool for batch-level quality control.
Palonosetron HCl CoA mostly includes findings from lab analyses of a specific batch. For each Palonosetron HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Palonosetron HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Palonosetron HCl EP), Palonosetron HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Palonosetron HCl USP).
Market Place
